Adil Usman, MD
Dermatology · Ashburn, VANPI 1932238037
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $405 of the $477 with a category attached, or 84.9%. It is spread thinly across 11 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $186 and has fallen 65.3% since, to $65 in 2025. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.
Across 20 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$82
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$74
- Johnson & Johnson$72
- AbbVie$71
- LEO Pharma Inc.$45
- Lilly USA, LLC$39
- plus $94 from 5 others
Across 5 payments — averaging $908.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$5K
What the payments were for
- Food & beverage$40585%
- Education$7215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $82 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $74 |
| Johnson & Johnson | 1 | $72 |
| AbbVie | 4 | $71 |
| LEO Pharma Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Pfizer | 2 | $34 |
| Incyte Corporation | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $13 |
| Organon | 1 | $8 |
How this compares
$477 in reported general payments places this provider in the 25th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $114,956 |
| Dapsone | 12 | $3,606 |
| Clobetasol Propionate | 74 | $3,212 |
| Fluorouracil | 43 | $3,164 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 60 | $1,287 |
| Metronidazole | 22 | $1,115 |
| Doxycycline Hyclate | 20 | $986 |
| Clindamycin Phosphate | 17 | $972 |
| Minocycline Hcl | 43 | $924 |
| Betamethasone Dipropionate | 11 | $648 |
| Cephalexin | 91 | $591 |
| Econazole Nitrate | 21 | $557 |
| Mometasone Furoate | 19 | $400 |
| Triamcinolone Acetonide | 27 | $266 |
| Hydrocortisone | 14 | $195 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ashburn
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.